AAAAAA
Results: 401-425/1162
Authors:
Horninger, W
Rogatsch, H
Reissigl, A
Volgger, H
Klocker, H
Hobisch, A
Bartsch, G
Citation: W. Horninger et al., Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening, PROSTATE, 40(1), 1999, pp. 56-61
Authors:
Isaacs, JT
Citation: Jt. Isaacs, Dr. Donald Straley Coffey - Preface, PROSTATE, 39(4), 1999, pp. 223-225
Authors:
Boesch, ST
Corvin, S
Zhang, J
Rogatsch, H
Bratsch, G
Klocker, H
Citation: St. Boesch et al., Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha I-adrenergic receptor antagonist, PROSTATE, 39(4), 1999, pp. 226-233
Authors:
Brawer, MK
Lin, DW
Williford, WO
Jones, K
Lepor, H
Citation: Mk. Brawer et al., Effect of finasteride and or terazosin on serum PSA: Results of VA cooperative study #359, PROSTATE, 39(4), 1999, pp. 234-239
Unique morphological aspects of the rat ventral prostate gland revealed byvascular corrosion casting
Authors:
Shabsigh, A
Lee, B
Buttyan, R
Citation: A. Shabsigh et al., Unique morphological aspects of the rat ventral prostate gland revealed byvascular corrosion casting, PROSTATE, 39(4), 1999, pp. 240-245
Authors:
Koeneman, KS
Yeung, F
Chung, LWK
Citation: Ks. Koeneman et al., Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment, PROSTATE, 39(4), 1999, pp. 246-261
Authors:
Ekman, P
Gronberg, H
Matsuyama, H
Kivineva, M
Bergerheim, USR
Li, CD
Citation: P. Ekman et al., Links between genetic and environmental factors and prostate cancer risk, PROSTATE, 39(4), 1999, pp. 262-268
Authors:
Denmeade, SR
Lin, XHS
Tombal, B
Isaacs, JT
Citation: Sr. Denmeade et al., Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells, PROSTATE, 39(4), 1999, pp. 269-279
Authors:
Wilkens, EP
Freije, D
Xu, JF
Nusskern, DR
Suzuki, H
Isaacs, SD
Wiley, K
Bujnovszky, P
Meyers, DA
Walsh, PC
Isaacs, WB
Citation: Ep. Wilkens et al., No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer, PROSTATE, 39(4), 1999, pp. 280-284
Authors:
Lee, C
Sintich, SM
Mathews, EP
Shah, AH
Kundu, SD
Perry, KT
Cho, JS
Ilio, KY
Cronauer, MV
Janulis, L
Sensibar, JA
Citation: C. Lee et al., Transforming growth factor-beta in benign and malignant prostate, PROSTATE, 39(4), 1999, pp. 285-290
Authors:
Simmons, SJ
Tjoa, BA
Rogers, M
Elgamal, A
Kenny, GM
Ragde, H
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Sj. Simmons et al., GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial, PROSTATE, 39(4), 1999, pp. 291-297
Authors:
Subong, ENP
Shue, MJ
Epstein, JI
Briggman, JV
Chan, PK
Partin, AW
Citation: Enp. Subong et al., Monoclonal antibody to prostate cancer nuclear matrix protein (PRO : 4-216) recognizes nucleophosmin/B23, PROSTATE, 39(4), 1999, pp. 298-304
Authors:
Pollard, M
Citation: M. Pollard, Prevention of prostate-related cancers in Lobund-Wistar rats, PROSTATE, 39(4), 1999, pp. 305-309
Authors:
Tiguert, R
Kabbani, W
Sakr, W
Gheiler, EL
Pontes, JE
Citation: R. Tiguert et al., Origin and racial distribution of glandular tissue in the anterior compartment of the prostate: An autopsy study, PROSTATE, 39(4), 1999, pp. 310-315
Authors:
Kranse, R
Beemsterboer, P
Rietbergen, J
Habbema, D
Hugosson, J
Schroder, FH
Citation: R. Kranse et al., Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region), PROSTATE, 39(4), 1999, pp. 316-322
Authors:
Coffey, DS
Citation: Ds. Coffey, The real final exam, PROSTATE, 39(4), 1999, pp. 323-325
Authors:
Bagshaw, MA
Citation: Ma. Bagshaw, Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer, PROSTATE, 39(3), 1999, pp. 151-152
Authors:
Mettlin, C
Chesley, AE
Murphy, GP
Bartsch, G
Toi, A
Bahnson, R
Church, P
Citation: C. Mettlin et al., Association of free PSA percent, total PSA, age, and gland volume in the detection of prostate cancer, PROSTATE, 39(3), 1999, pp. 153-158
Authors:
Arcuri, F
del Vecchio, MT
de Santi, MM
Lalinga, AV
Pallini, V
Bini, L
Bartolommei, S
Parigi, S
Cintorino, M
Citation: F. Arcuri et al., Macrophage migration inhibitory factor in the human prostate: Identification and immunocytochemical localization, PROSTATE, 39(3), 1999, pp. 159-165
Authors:
Santourlidis, S
Florl, A
Ackermann, R
Wirtz, HC
Schulz, WA
Citation: S. Santourlidis et al., High frequency of alterations in DNA methylation in adenocarcinoma of the prostate, PROSTATE, 39(3), 1999, pp. 166-174
Authors:
Mikkola, AKK
Aro, JLV
Rannikko, SAS
Salo, JO
Citation: Akk. Mikkola et al., Pretreatment plasma testosterone and estradiol levels in patients with locally advanced or metastasized prostatic cancer, PROSTATE, 39(3), 1999, pp. 175-181
Authors:
Wang, XO
An, Z
Geller, J
Hoffman, RM
Citation: Xo. Wang et al., High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP, PROSTATE, 39(3), 1999, pp. 182-186
Authors:
Blomme, EAG
Dougherty, KM
Pienta, KJ
Capen, CC
Rosol, TJ
McCauley, LK
Citation: Eag. Blomme et al., Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone-related protein, PROSTATE, 39(3), 1999, pp. 187-197
Authors:
Loch, T
Leuschner, I
Genberg, C
Weichert-Jacobsen, K
Kuppers, F
Yfantis, E
Evans, M
Tsarev, V
Stockle, M
Citation: T. Loch et al., Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound, PROSTATE, 39(3), 1999, pp. 198-204
Authors:
Hayward, SW
Haughney, PC
Lopes, ES
Danielpour, D
Cunha, GR
Citation: Sw. Hayward et al., The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment, PROSTATE, 39(3), 1999, pp. 205-212